TherapeuticsMD (TXMD) Net Equity Issued and Repurchased (2012 - 2023)
TherapeuticsMD (TXMD) reported Net Equity Issued and Repurchased of $2 million for Q4 2023.
Powered by 
Analysis
TherapeuticsMD (TXMD) Net Equity Issued and Repurchased (2012 - 2023) Analysis & Trends
For FY2023, TherapeuticsMD posted Net Equity Issued and Repurchased of $3.15 million, up 28.4% from FY2022.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of -48.8% (FY2018 to FY2023).
- By year, Net Equity Issued and Repurchased came in at $2.45 million in FY2022 (-98.7%), $184.12 million in FY2021 (+480.7%), $31.7 million in FY2020 (-58.8%) and $77.03 million in FY2019 (-14.3%).
- The Q4 2023 figure ranks as the highest quarterly Net Equity Issued and Repurchased since Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.06 Bn | 1,133.65 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 643.87 Bn | 563.73 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 501.19 Bn | 474.31 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 357.68 Bn | 312.06 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 301.88 Bn | 265.87 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.25 Bn | 240.94 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 241.08 Bn | 196.48 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 192.57 Bn | 166.76 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 171.48 Bn | 118.13 Bn | 10.94 Bn | - |
| 10 | TherapeuticsMD | 21.41 Mn | 21.41 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | -1,000.00 |
| Dec 31, 2022 | 5.42 Mn |
| Dec 31, 2021 | 1.25 Mn |
| Sep 30, 2021 | 31.82 Mn |
| Jun 30, 2021 | 412,000.00 |
| Mar 31, 2021 | 150.95 Mn |
| Dec 31, 2020 | 31.70 Mn |
| Sep 30, 2020 | 106,000.00 |
| Jun 30, 2020 | 94,000.00 |
| Mar 31, 2020 | 72,000.00 |
| Dec 31, 2019 | 77.03 Mn |
| Sep 30, 2019 | 8,549.00 |
| Mar 31, 2019 | 100,107.00 |
| Dec 31, 2018 | 429,895.00 |
| Sep 30, 2018 | 90.02 Mn |
| Jun 30, 2018 | 1.08 Mn |
| Mar 31, 2018 | 44,057.00 |
| Sep 30, 2017 | 68.57 Mn |
| Jun 30, 2017 | 1.36 Mn |
API Access
TherapeuticsMD Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();